Madam Chair, we are grateful that the manufacturers are submitting the data as quickly as they acquire it. As they acquire the data necessary to complete those reviews, we will review that data expeditiously. We have regulators working on reviewing the data 24 hours a day, seven days a week. When they are safe for Canadians, we will approve them and vaccines will be available.
In the House of Commons on November 26th, 2020. See this statement in context.